Olleyes, Inc., a leader in innovative ophthalmic technology, today announced the launch of a new Stereopsis Test within its VisuALL Virtual Reality Platform (VRP).
Reishi mushroom market size generated at $3.09 billion in 2019, and is anticipated to reach $5.06 billion by 2027, registering with a CAGR of 8.1% from 2021 to 2027.
One of Melbourne’s busiest trams, the No. 86, has become a moving billboard for change, showcasing the bold and empowering FLIP THE VAPE campaign, which is reshaping the way anti-vaping messages are delivered to Aboriginal and Torres Strait Islander youth across Victoria.
Sleep Electric has officially operated for over 10 years now as a registered provider under the National Disability Insurance Scheme (NDIS) in Western Australia.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF) announces the Preliminary Final Report and Annual Report.
Healthcare executives, business development leaders, and HR directors in healthcare organizations, or even in SMEs, face mounting pressures. Rising operational costs, administrative burdens, and increasing demand for efficient patient care clearly require innovative solutions that would keep businesses alive and to thrive in this volatile economic landscape.
King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has introduced a cutting-edge brain implant that leverages artificial intelligence to detect abnormal brain signals and deliver targeted stimulation in real time.
